November 09, 2020:
On November 9, Advarra announced its acquisition of IntegReview IRB. The combined organization leverages strengths in supporting the research community with client service, regulatory expertise, and technology-enabled efficiencies to accelerate innovation, streamline research operations, support faster study startup, and advance clinical trials.
September 15, 2020: IntegReview Receives Full AAHRPP Reaccreditation
May 28, 2019: IntegReview IRB is Pleased to Announce the Latest FDA Routine Audit Finds No Deficiencies
July 11, 2018: IntegReview IRB Adds Renowned Professor Emeritus, Ernest D. Prentice, Ph.D. to Team as Senior Consultant [READ FULL PRESS RELEASE HERE]
May 16, 2017: IntegReview IRB and Veritas IRB announce partnership to provide accredited ethics review services in the U.S. and Canada [READ FULL PRESS RELEASE HERE]
Quarterly IRB Newsletters
To sign up to receive our Newsletters via email, please click on the link in the footer of this page and complete the sign-up form.
2020 Quarterly Newsletters:
Melanie Flores, CIP, CCRP joins snapIoT, Leo Pharma, and Studies&Me in a webinar discussion on "Evaluating Global eConsent Use Cases". Melanie provides the IRBs perspective on the regulatory and IRB requirements on eConsent.
Watch the webinar here.
Melanie Flores, CIP, CCRP sits down with Curebase CEO, Tom Lemberg for a candid conversation on the "IRB Perspective on Decentralized Clinical Trials".
Watch the webinar here.
New President of IntegReview IRB - We are excited to announce Melanie Flores, CIP, CCRP (formally Vice President of Compliance) as the Company's new President. In this role, Melanie will oversee the Operations, Regulatory Compliance and Client Services functions. We are very excited about her new journey!
Coronavirus Disease 2019 (COVID-19) - IntegReview IRB, like the general public, is concerned about the growing spread of the Coronavirus and we understand that many may be concerned about the status of their research participants/site staff safety, welfare, or the implication on study recruitment or conduction. Due to this pandemic, we understand that changes may be necessary in your IRB-approved research that will require initiation without IRB approval to eliminate apparent immediate hazards to the research participants. In keeping in line with our Company policies and Federal regulations, please report these necessary changes promptly to IntegReview for IRB review. We want to reassure you that IntegReview IRB has a business continuity plan in place to ensure that there is no disruption in the services we provide to you. IRB meetings will be planned as scheduled and meeting deadlines will remain the same as indicated on our website [click here to view Meeting & Submission Deadlines].
2020 Upcoming Events
|DATE||CONFERENCE / EVENT||LOCATION||ASSOCIATION|
|3Q and 4Q||Upcoming Webinars|
Future conferences (exhibitor and attendence) will be updated shortly as travel restrictions are updated. #Staywell